Cannabinoid Clinical Trials: Anxiety & Tourette Syndrome
Cannabinoid clinical trials anxiety disorders reveal modest evidence for CBD in reducing acute anxiety symptoms. THC-dominant formulations may increase anxiety and are not recommended. More rigorous trials are needed to establish cannabinoids as…
Why CBD Affects Anxiety Differently in Each Person
Variable CBD response anxiety is influenced by genetic and biochemical factors unique to each person. This research highlights why CBD affects anxiety differently among individuals. Understanding these differences helps clinicians tailor personalized…
Cannabidiol Effects on Autism Anxiety and Parental Stress
This study examines effects cannabidiol autism anxiety parental stress in children aged 5-12 years. CBD oil at 10 mg/kg/day showed improvements in social relating and anxiety symptoms. Parental stress levels also decreased compared to placebo in this…
Clinical Research on Cannabis Derivatives for Autism
Cannabis derivatives autism clinical trials indicate potential benefits for behavioral challenges and anxiety in autism spectrum disorder. Current evidence is limited by small sample sizes and varied outcome measures. Larger randomized controlled trials…
CBD Dominant Cannabis Anxiety Relief: Study Insights
This CBD dominant cannabis anxiety relief study highlights the anxiolytic benefits of CBD-containing products over 30 days. Findings show significant anxiety reduction compared to THC-only products. The study emphasizes the importance of cannabinoid…
Clinical Trial of CBD Oil Effects on Autism and Anxiety
The CBD oil autism anxiety trial demonstrated measurable improvements in social relating and anxiety symptoms in autistic children. This randomized controlled study used a weight-based dosing approach over 12 weeks. Findings suggest potential benefits of…
Clinical Trials of CBD for Anxiety and Tourette
CBD anxiety clinical trials demonstrate promising efficacy for generalized and social anxiety disorders with good safety. THC formulations show mixed results and possible anxiety worsening at high doses. Current evidence supports CBD as an adjunctive…
Exploring the Internalising Pathway of Cannabis Use in Teens
The internalising pathway cannabis use teens highlights how anxiety symptoms increase the risk of cannabis initiation and escalation. Adolescents with generalised anxiety are particularly vulnerable. Early intervention targeting these symptoms may reduce…
Daily Cannabis Use and Anxiety Relief: Outcomes by Product Type
Daily cannabis anxiety relief outcomes vary significantly by product type and cannabinoid composition. Research shows that flower and edible cannabis products produce different anxiety symptom changes over time. Understanding these outcomes helps guide…
Medical marijuana rescheduling is legally puzzling but still a ‘huge win’ for patients
The medical cannabis rescheduling from Schedule I to Schedule III marks a major federal policy change. This shift facilitates clinical research and improves patient access to medical marijuana. Despite legal ambiguities, medical cannabis rescheduling is…
